
Manoj Ghimire
@ghimiremanoj001
ID: 913747343740092416
29-09-2017 12:48:38
45 Tweet
59 Followers
239 Following

Many thanks to The Lancet The Lancet Global Health for listening to the voices of the LMICs.








Congrats to our research trainees Manoj Ghimire Shahin Isha Parth Satashia, MBBS for presenting their work at the Society of Critical Care Medicine's 2023 conference. Thanks to Anirban Bhattacharyya Devang Sanghavi, MD, MHA, FCCP Sanjay Chaudhary Pramod K Guru.MBBS,MD,DM,FASN Pablo Moreno Franco for their mentorship and support! 💪🙌


Congratulations to our ACRC graduates for the Residency Match! Upwards and onwards 🙌💪#Match2023 Sai Abhishek Narra Ananya Vasudhar Gunjan Mundhra @BatoolHumera Jorge Sinclair Manoj Ghimire Parth Satashia, MBBS Rabi Shrestha Dr.Subekshya Khadka @smitpaghdar Shahin Isha Trisha Singh



We are thrilled to inform you that our team had collectively 22 abstracts accepted for CHEST 2023! Extremely proud of our team and grateful for the guidance from our mentors Anirban Bhattacharyya Devang Sanghavi, MD, MHA, FCCP Pablo Moreno Franco Pramod K Guru.MBBS,MD,DM,FASN and others in ACRC. See you in Hawaii! CHEST



AKI before ECMO initiation and the need for RRT post-ECMO are independently associated with poor patient survival among patients on ECMO support. Thanks to Pramod K Guru.MBBS,MD,DM,FASN Acute Care Research Consortium MayoPCCM Mayo Clinic Critical Care Medicine Fellowship Mayo Clinic Further reading below: sciencedirect.com/science/articl…

🙋Take Home Messages📝 1️⃣ #AKI is Common during #ECMO support 2️⃣Half(~50%)had AKI prior to ECMO cannulation 3️⃣Pre- ECMO AKI & Post-ECMO RRT is associated with increase mortality Kianoush Kashani M Velia Antonini ELSOed sciencedirect.com/science/articl…

Are you a resident interested in cardio? #ACC24 gives us the tools to develop skills and competencies for our #cardiology fellowship! These are some of the conferences I won't miss! American College of Cardiology see you there!


Takeaways from #ACC2024. Late breaking trials - take home points American College of Cardiology 1. RELIEVE-HF Trial: In patients with HFrEF and HFpEF, Interatrial Shunt did not show any significant difference in the primary effectiveness endpoint, a composite of all-cause mortality, LVAD/heart

Our residents and alumni were part of the #ACC24 ! They presented several abstracts and represented our program SBH Internal Medicine ! Our president was a #SoMe ambassador! Also several of them are part of the IM/CV cohort! American College of Cardiology #friends #cardio #CardioTwitter


